Integrating Pharmacovigilance and Materiovigilance programs for enhanced sustainability

Raghuvanshi Rajeev Singh

Indian Pharmacopoeia Commission (IPC), INDIA


The Indian Pharmacopoeia Commission (IPC) under the Ministry of Health & Family Welfare, Government of India is an authoritative organization to promote the quality and safety of medicines in India. The IPC besides publishing Indian Pharmacopoeia (official book of standards for drugs and pharmaceuticals) and National Formulary of India (NFI) also coordinates the Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI) to ensure and promote the safety of medicines and medical devices respectively. The IPC also functions as WHO Collaborating Centre for Pharmacovigilance; through this collaboration IPC provides support to WHO for promoting Pharmacovigilance at the global level. The IPC takes several measures and intervention to improve the culture of spontaneous reporting even at the primary health care level. Efforts have been made to approach the state governments to ensure their district level hospitals and medical colleges to participate in PvPI and MvPI. India also one of the top ten countries of adverse events reporting to WHO's international drug monitoring programme. The IPC working towards to promote both PvPI and MvPI as patient centric activity to ensure the safety of medicines and medical devices respectively. Also its pivotal and need of the hour to integrate these two programmes with similarly placed academic and research institutions as research based interventions will enhance the sustainability.  

Article ID: O0401019 (Suppl 1)   RA  Preprint
Received: 08/06/2022 
Accepted: 08/07/2022
Published: 08/08/2022

How to cite this paper